Clinical trial
A Phase 2, Double-Blind Randomized, Placebo-Controlled, Parallel Group, Multicenter Study to Evaluate Treatment With SYR-619 in Subjects With Type 2 Diabetes
NCT00763347 is registered in ClinicalTrials.gov with Takeda as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2, Double-Blind Randomized, Placebo-Controlled, Parallel Group, Multicenter Study to Evaluate Treatment With SYR-619 in Subjects With Type 2 Diabetes
- Lead sponsor
- Takeda
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- November 30, 2006
- Completion date
- February 28, 2007
- Enrollment
- 82 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.